RION ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1B CLINICAL STUDY EVALUATING PURIFIED EXOSOME PRODUCT™ (PEP™) FOR KNEE OSTEOARTHRITIS

Reuters · 5d ago

Please log in to view news